Josh Feng

Cited by

	All	Since 2019
Citations	198	179
h-index	6	6
i10-index	5	5

20152016201720182019202020212022202320241 1 6 9 19 18 29 37 63 13

Public access

View all

7 articles

0 articles

available

not available

Based on funding mandates

Co-authors

Xavier JaravelLondon School of EconomicsVerified email at lse.ac.uk
Luca MainiAssistant Professor, Harvard Medical SchoolVerified email at hcp.med.harvard.edu
Aaron KesselheimProfessor of Medicine, Harvard Medical School & Brigham and Women's HospitalVerified email at partners.org
Stacie DusetzinaVanderbilt University Medical CenterVerified email at vanderbilt.edu
Elias EiniöVATTVerified email at vatt.fi
Jacob KlimekUniversity of North Carolina at Chapel HillVerified email at live.unc.edu
Elena PatelUniversity of UtahVerified email at eccles.utah.edu
Matthew J. HigginsEmma Eccles Jones Chair & Professor of Entrepreneurship & Strategy, David Eccles School of BusinessVerified email at eccles.utah.edu
Emma B. DeanAssistant Professor of Health Management and Policy, University of MiamiVerified email at bus.miami.edu

Josh Feng

Other namesJiashuo Feng

University of Utah, David Eccles School of Business

Verified email at eccles.utah.edu - Homepage

Industrial Organization Innovation & Entrepreneurship Intellectual Property Health Economics


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Crafting intellectual property rights: Implications for patent assertion entities, litigation, and innovation J Feng, X Jaravel American Economic Journal: Applied Economics 12 (1), 140-181, 2020	98*	2020
Price increases of protected-class drugs in Medicare Part D, relative to inflation, 2012-2017 TJ Hwang, SB Dusetzina, J Feng, L Maini, AS Kesselheim JAMA 322 (3), 267-269, 2019	25	2019
Social Push and the Direction of Innovation E Einio, J Feng, X Jaravel Available at SSRN 3383703, 2019	21	2019
History-dependence in drug demand: Identification and implications for entry incentives J Feng Review of Economics and Statistics 106 (2), 455-469, 2024	17*	2024
Demand Inertia and the Hidden Impact of Pharmacy Benefit Managers J Feng, L Maini Management Science, 2024	11*	2024
Profiting from most-favored customer procurement rules: Evidence from medicaid J Feng, T Hwang, L Maini American Economic Journal: Economic Policy 15 (2), 166-197, 2023	9*	2023
Medicaid expenditures and estimated rebates on line extension drugs, 2010–2018 TJ Hwang, J Feng, L Maini, AS Kesselheim Journal of General Internal Medicine 37 (14), 3769-3771, 2022	5	2022
Biosimilar entry and the pricing of biologic drugs L Maini, J Feng, T Hwang, J Klimek Available at SSRN 3760213, 2021	5	2021
Abstract Patents and Innovation: Evidence from Alice v. CLS Bank J Feng, P Williams SSRN Working Paper, 2023	2	2023
Pour une stratégie nationale d’innovation par tous JJ Feng, X Jaravel, E Richard Focus du CAE, 2022	2	2022
Where is the good stuff? Drug quality measures and economic research J Feng, L Maini Harvard University working paper. Google Scholar, 2016	2	2016
Mergers that Matter: The Impact of M&A Activity in Prescription Drug Markets J Feng, T Hwang, Y Liu, L Maini Tech. rep., University of Utah, 2023	1	2023
Stocking Under the Influence: Spillovers from Commercial Drug Coverage to Medicare Utilization E Boswell Dean, J Feng, L Maini Available at SSRN 4578352, 2023		2023
Pediatric Drug Adherence and Parental Attention: Evidence from Comprehensive Claims Data J Feng, MJ Higgins, E Patel National Bureau of Economic Research, 2023		2023
Essays on Industrial Organization and Innovation J Feng Harvard University, 2018		2018

The system can't perform the operation now. Try again later.

Articles 1–15

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors